Who to call at AbCellera Biologics Inc., and when
Fundz watches for the moments AbCellera Biologics Inc. starts buying, and tells you who to reach.
- An alert the day AbCellera Biologics Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AbCellera Biologics Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AbCellera Biologics Inc.. With Fundz connected, it knows.
AbCellera Biologics Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
abcellera.comAI Executive Summary
AI-powered analysis of 8-K filing content
AbCellera Biologics appointed Stephen Quake, D.Phil. as an independent director effective November 10, 2025, while Andrew Lo, Ph.D. resigned from the Board the same day, with no disagreement cited. The change adds Quake to the Audit and Nominating and Corporate Governance Committees.
Key Takeaways
Stephen Quake, D.Phil. was appointed to the Board on November 10, 2025, and the Board determined he is independent under NASDAQ rules and the Company's Corporate Governance Guidelines.
Quake joins the Audit Committee and the Nominating and Corporate Governance Committee, placing a new independent director on two key oversight committees.
3 more takeaways
Related Filings (13)
13 more filings from AbCellera Biologics Inc. in the last 90 days
Filing Overview
What This Means
AbCellera Biologics Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.